U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
85.09
-1.36 (-1.57%)
At close: Feb 20, 2026, 4:00 PM EST
85.16
+0.07 (0.08%)
After-hours: Feb 20, 2026, 7:00 PM EST

U.S. Physical Therapy Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,2941,3391,3961,0541,2341,545
Market Cap Growth
-3.27%-4.07%32.50%-14.61%-20.16%5.79%
Enterprise Value
1,5701,6631,6811,4271,4901,768
Last Close Price
85.0986.6589.3076.3488.42109.82
PE Ratio
35.8148.2976.9536.0039.6148.63
Forward PE
30.1032.9334.0229.1530.0239.57
PS Ratio
1.722.022.331.922.523.69
PB Ratio
2.571.762.142.172.733.77
P/FCF Ratio
22.7420.3619.2020.9518.0916.73
P/OCF Ratio
18.6117.8717.0318.0016.1515.45
PEG Ratio
3.563.864.613.242.503.04
EV/Sales Ratio
2.092.502.812.613.044.23
EV/EBITDA Ratio
15.8018.7619.6817.6818.1228.09
EV/EBIT Ratio
20.6923.7624.1121.6321.0933.74
EV/FCF Ratio
27.5925.2923.1328.3721.8519.15
Debt / Equity Ratio
0.390.390.400.610.490.31
Debt / EBITDA Ratio
1.962.101.932.401.821.24
Debt / FCF Ratio
5.424.493.565.873.271.35
Net Debt / Equity Ratio
0.350.330.160.540.430.23
Net Debt / EBITDA Ratio
2.782.841.213.232.371.46
Net Debt / FCF Ratio
4.863.831.425.192.851.00
Asset Turnover
0.680.610.650.680.730.72
Quick Ratio
1.071.112.201.211.090.90
Current Ratio
1.201.182.281.301.140.94
Return on Equity (ROE)
8.44%6.46%6.55%9.26%13.43%13.30%
Return on Assets (ROA)
4.26%4.04%4.70%5.13%6.57%5.67%
Return on Invested Capital (ROIC)
5.47%6.00%7.00%7.40%9.73%8.43%
Return on Capital Employed (ROCE)
7.00%6.70%7.80%8.50%10.60%10.50%
Earnings Yield
2.78%2.35%2.02%3.05%3.31%2.28%
FCF Yield
4.40%4.91%5.21%4.77%5.53%5.98%
Dividend Yield
2.12%2.03%1.93%2.15%1.65%0.29%
Payout Ratio
75.75%84.46%85.44%66.30%45.96%11.68%
Buyback Yield / Dilution
-0.77%-6.17%-9.26%-0.68%-0.49%-0.62%
Total Shareholder Return
1.35%-4.14%-7.34%1.47%1.16%-0.33%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q